On Monday, November 16, 2020, the Company, Clovis Oncology, Inc., CLVS stock construct a change of 3.76 percent (Gain) in a total of its share price and having its trading value $4.42, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $378.48M with the total Outstanding Shares of 88.26M.
P/S, P/E, P/B & P/C values of (NASDAQ: CLVS):
Clovis Oncology, Inc. institutional ownership is standing at 55.7 percent, while insider ownership is 0.4 percent. As of now, CLVS has a P/S, P/E and, P/B values of 2.36, 0, and 0 respectively. Its P/Cash is valued at 1.68.
The stock SMA50 is now at -21.89 percent. In looking, the SMA 200 we see that the stock has seen a -33.7 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 75.3 percent.
Looking into the profitability ratios of CLVS stock, an investor will find its ROE, ROA, ROI standing at 263.2 percent, -59.3 percent and, -76.5 percent, respectively.
A beta factor is used to measure the volatility of the stock. The stock remaining at 4.63 percent volatile for the week and 6 percent for the month.
Gross / Operating Margins of CLVS:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 75.3 percent & Operating Margin seen at 0 percent.
Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Clovis Oncology, Inc. recorded it at $7.33.
Historical Performance In The News:
Taking a look at the performance of Clovis Oncology, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 6 percent, resulting in a performance for the month at -26.27 percent.
Therefore, the stated figure displays a quarterly performance of -24.96 percent, bringing six-month performance to -41.22 percent and year to date performance of -57.6 percent. As of now, Clovis Oncology, Inc. has a P/S, P/E and, P/B values of 2.36, 0, and 0 respectively. Its P/Cash is valued at 1.68.
Earnings per Share Details of Clovis Oncology, Inc.:
The EPS of CLVS is strolling at -5.24, measuring its EPS growth this year at -5.2 percent. As a result, the company has an EPS growth of 43.2 percent for the approaching year.